-
Something wrong with this record ?
Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells
M. Kořínek, V. Sístek, J. Mládková, P. Mikeš, J. Jiráček, I. Selicharová,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
22653757
DOI
10.1002/bmc.2755
Knihovny.cz E-resources
- MeSH
- Betaine-Homocysteine S-Methyltransferase metabolism MeSH
- Hep G2 Cells MeSH
- Chromatography, Liquid MeSH
- Homocysteine analogs & derivatives analysis chemistry metabolism MeSH
- Calibration MeSH
- Humans MeSH
- Linear Models MeSH
- Reproducibility of Results MeSH
- Sensitivity and Specificity MeSH
- Tandem Mass Spectrometry MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
We optimized and validated a rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of six metabolites of homocysteine metabolism: homocysteine, methionine, cysteine, S-adenosylmethionine, S-adenosylhomocysteine and betaine. The detection limits for these metabolites were in the nanomolar range, and the intra- and inter-day precisions were lower than 20% of the relative standard deviations. The method was specifically designed for the determination of the intracellular concentrations of the metabolites in cultured cells. To study the role of betaine-homocysteine S-methyltransferase (BHMT), HepG2 cells and HepG2 cells that were stably transfected with BHMT ((BHMT) HepG2) were treated with homocysteine or with a specific inhibitor of BHMT, and metabolite levels were subsequently measured. Severely compromised methyl group metabolism in the HepG2 cells, which is typical of cancer-derived cells, prevented clear evaluation of the changes caused by the external manipulations of homocysteine metabolism. However, the ease of handling these cells and the almost unlimited source of experimental material supplied by cells in permanent culture allowed us to develop a reliable methodology. The precautions concerning intracellular metabolite determinations using LC-MS/MS in cultured cells that are expressed in this work will have global validity for future metabolomics studies.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024423
- 003
- CZ-PrNML
- 005
- 20130704125216.0
- 007
- ta
- 008
- 130703s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/bmc.2755 $2 doi
- 035 __
- $a (PubMed)22653757
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kořínek, Marek $u Apigenex s.r.o., Poděbradská 186/56, Prague 9, Czech Republic.
- 245 10
- $a Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells / $c M. Kořínek, V. Sístek, J. Mládková, P. Mikeš, J. Jiráček, I. Selicharová,
- 520 9_
- $a We optimized and validated a rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of six metabolites of homocysteine metabolism: homocysteine, methionine, cysteine, S-adenosylmethionine, S-adenosylhomocysteine and betaine. The detection limits for these metabolites were in the nanomolar range, and the intra- and inter-day precisions were lower than 20% of the relative standard deviations. The method was specifically designed for the determination of the intracellular concentrations of the metabolites in cultured cells. To study the role of betaine-homocysteine S-methyltransferase (BHMT), HepG2 cells and HepG2 cells that were stably transfected with BHMT ((BHMT) HepG2) were treated with homocysteine or with a specific inhibitor of BHMT, and metabolite levels were subsequently measured. Severely compromised methyl group metabolism in the HepG2 cells, which is typical of cancer-derived cells, prevented clear evaluation of the changes caused by the external manipulations of homocysteine metabolism. However, the ease of handling these cells and the almost unlimited source of experimental material supplied by cells in permanent culture allowed us to develop a reliable methodology. The precautions concerning intracellular metabolite determinations using LC-MS/MS in cultured cells that are expressed in this work will have global validity for future metabolomics studies.
- 650 _2
- $a betain-homocystein-S-methyltransferasa $x metabolismus $7 D050940
- 650 _2
- $a kalibrace $7 D002138
- 650 _2
- $a chromatografie kapalinová $7 D002853
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a homocystein $x analogy a deriváty $x analýza $x chemie $x metabolismus $7 D006710
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a tandemová hmotnostní spektrometrie $7 D053719
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sístek, Václav $u -
- 700 1_
- $a Mládková, Jana $u -
- 700 1_
- $a Mikeš, Petr $u -
- 700 1_
- $a Jiráček, Jiří $u -
- 700 1_
- $a Selicharová, Irena $u -
- 773 0_
- $w MED00000817 $t Biomedical chromatography : BMC $x 1099-0801 $g Roč. 27, č. 1 (2013), s. 111-21
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22653757 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130704125634 $b ABA008
- 999 __
- $a ok $b bmc $g 988103 $s 822803
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 27 $c 1 $d 111-21 $i 1099-0801 $m BMC. Biomedical chromatography $n Biomed Chromatogr $x MED00000817
- LZP __
- $a Pubmed-20130703